TeraCyte Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 2

TeraCyte General Information

Description

Developer of computational models designed to predict cellular responses to various stimuli. The company offers analytical capabilities, facilitating the understanding and forecasting of cell reactions to new drugs or perturbations in the medical field, enabling pharmaceutical researchers and medical professionals to make informed decisions regarding drug development and treatment strategies.

Contact Information

Website
www.teracyte.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Granite Campus
  • Ha-Tokhen Street 17, Industrial Park North
  • Caesarea
  • Israel
Primary Industry
Other Healthcare Technology Systems
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Corporate Office
  • Granite Campus
  • Ha-Tokhen Street 17, Industrial Park North
  • Caesarea
  • Israel

TeraCyte Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TeraCyte Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 01-Mar-2026 Completed Generating Revenue
2. Accelerator/Incubator 01-Jun-2023 Completed Generating Revenue
1. Seed Round 04-Apr-2023 $1.55M $1.55M Completed Startup
To view TeraCyte’s complete valuation and funding history, request access »

TeraCyte Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 1
Seed 2
To view TeraCyte’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

TeraCyte Patents

TeraCyte Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026115390-A1 System and methods for artificial intelligence inference of cell phenotype using an integrated biosensor Pending 26-Nov-2024
EP-4623287-A1 Silicon-on-insulator (soi) carrier chip and methods of manufacture thereof Pending 27-Nov-2022
US-20250283820-A1 Silicon-on-insulator (soi) carrier chip and methods of manufacture thereof Pending 27-Nov-2022
WO-2024110940-A1 Silicon-on-insulator (soi) carrier chip and methods of manufacture thereof Inactive 27-Nov-2022
WO-2024110960-A1 System and methods for temporal image analysis of multi-cell interaction using a carrier chip Inactive 23-Nov-2022 G06T7/0012
To view TeraCyte’s complete patent history, request access »

TeraCyte Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TeraCyte Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Stata Capital Partners Venture Capital Minority
MedTech Innovator Accelerator/Incubator Minority
To view TeraCyte’s complete investors history, request access »

TeraCyte FAQs

  • When was TeraCyte founded?

    TeraCyte was founded in 2019.

  • Where is TeraCyte headquartered?

    TeraCyte is headquartered in Caesarea, Israel.

  • What is the size of TeraCyte?

    TeraCyte has 20 total employees.

  • What industry is TeraCyte in?

    TeraCyte’s primary industry is Other Healthcare Technology Systems.

  • Is TeraCyte a private or public company?

    TeraCyte is a Private company.

  • What is TeraCyte’s current revenue?

    The current revenue for TeraCyte is .

  • How much funding has TeraCyte raised over time?

    TeraCyte has raised $1.55M.

  • Who are TeraCyte’s investors?

    Stata Capital Partners and MedTech Innovator have invested in TeraCyte.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process